2023
DOI: 10.1016/j.jep.2022.115775
|View full text |Cite
|
Sign up to set email alerts
|

Hypouricemic and nephroprotective effects of palmatine from Cortex Phellodendri Amurensis: A uric acid modulator targeting Keap1-Nrf2/NLRP3 axis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 60 publications
0
6
0
Order By: Relevance
“…Atractylenolide I can alleviate hyperuricemia through AGE‐RAGE‐ and HIF‐1‐related pathways [22]. Palmatine improve hyperuricemia by regulating the expression of urate transport‐related protein URAT1 and inhibiting the expression of xanthine oxidase [23]. In addition, palmatine can upregulate the expression of NQO1, GCLC, GCLM, and HO‐1, downregulate the expression of Keap1, and promote Nrf2 translocation to reduce uric acid and protecting kidney [23].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Atractylenolide I can alleviate hyperuricemia through AGE‐RAGE‐ and HIF‐1‐related pathways [22]. Palmatine improve hyperuricemia by regulating the expression of urate transport‐related protein URAT1 and inhibiting the expression of xanthine oxidase [23]. In addition, palmatine can upregulate the expression of NQO1, GCLC, GCLM, and HO‐1, downregulate the expression of Keap1, and promote Nrf2 translocation to reduce uric acid and protecting kidney [23].…”
Section: Resultsmentioning
confidence: 99%
“…Palmatine improve hyperuricemia by regulating the expression of urate transport‐related protein URAT1 and inhibiting the expression of xanthine oxidase [23]. In addition, palmatine can upregulate the expression of NQO1, GCLC, GCLM, and HO‐1, downregulate the expression of Keap1, and promote Nrf2 translocation to reduce uric acid and protecting kidney [23]. Atractylenolide II and atractylenolide III upregulate the expression of PPAR‐α and downregulate the expression of PPAR‐γ and Glut4 by activating AMPK signaling pathway for lowering blood sugar and blood lipid levels [24, 25].…”
Section: Resultsmentioning
confidence: 99%
“…It has various pharmacological properties, such as antibacterial and anti-inflammatory activities, liver and kidney protection, and uric acid-lowering effects. [ 59 ] Researchers have found that PAL decreases the mRNA expression and levels of pro-inflammatory cytokines in a dose-dependent manner. Superoxide dismutase (SOD) and glutathione (GSH) levels were remarkably enhanced, while malondialdehyde levels were reduced.…”
Section: Resultsmentioning
confidence: 99%
“…The increasing requirements for quality control of TCMs have resulted in the gradual replacement of the traditional single-compound measurement method with multi-component measurement, which has become a prominent approach in evaluating quality [21,22]. Various chemical compounds have been extracted from PAC, mainly concentrated on alkaloids that are considered to be the primary bioactive constituents contributing to its overall pharmacological effects [23,24] The diverse configurations of alkaloids exhibit varying biological activities in order to achieve therapeutic effects. The selected index ingredients in this study were chosen to be highly correlated with clinical efficacy to the greatest extent possible.…”
Section: Discussionmentioning
confidence: 99%